Longitudinal Study of New Eye Lesions in Treated Congenital Toxoplasmosis

Ophthalmology

Volumn 115, Issue 3, 2008, Pages

  Phan, Laura ^a   Kasza, Kristen ^b   Jalbrzikowski, Jessica ^a   Noble, A Gwendolyn ^c   Latkany, Paul ^a,d   Kuo, Annie ^a   Mieler, William ^a   Meyers, Sanford ^a   Rabiah, Peter ^a   Boyer, Ken ^e   Swisher, Charles ^c   Mets, Marilyn ^c   Roizen, Nancy ^a,f   Cezar, Simone ^a   Remington, Jack ^g   Meier, Paul ^a,h   McLeod, Rima ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g STANFORD UNIVERSITY   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CLARITHROMYCIN; CLINDAMYCIN; FOLINIC ACID; PYRIMETHAMINE; SULFADIAZINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHORIORETINAL LESION; CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; CONGENITAL TOXOPLASMOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EYE EXAMINATION; EYE FUNDUS; EYE INFECTION; EYE INJURY; FEMALE; FOLLOW UP; HUMAN; INFANT; LONGITUDINAL STUDY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBSERVATIONAL STUDY; PHOTOGRAPHY; PRIORITY JOURNAL;

EID: 39749127160     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.06.022     Document Type: Article

References (24)

1. J.G. Koppe D.H. Loewer-Sieger H. de Roever-Bonnet Results of 20-year follow-up of congenital toxoplasmosis Lancet 1 1986 254 256
2. C.B. Wilson J.S. Remington S. Stagno D.W. Reynolds Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection Pediatrics 66 1980 767 774
3. M.B. Mets E. Holfels K.M. Boyer Eye manifestations of congenital toxoplasmosis Am J Ophthalmol 122 1996 309 324
4. J. McAuley K.M. Boyer D. Patel Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial Clin Infect Dis 18 1994 38 72
5. R. McLeod K. Boyer T. Karrison Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based Congenital Toxoplasmosis Study Clin Infect Dis 42 2006 1383 1394
6. R. McLeod A.R. Khan A.G. Noble Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis Pediatr Infect Dis J 25 2006 270 272
7. N. Roizen C.N. Swisher M.A. Stein Neurologic and developmental outcome in treated congenital toxoplasmosis Pediatrics 95 1995 11 20
8. K. Boyer E. Holfels N. Roizen Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal treatment and screening Am J Obstet Gynecol 192 2005 564 571
9. C. Binquet M. Wallon C. Quantin Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis Epidemiol Infect 131 2003 1157 1168
10. A.P. Brézin P. Thulliez J. Couvreur Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis Am J Ophthalmol 135 2003 779 784
11. M.E. Grigg J. Ganatra J.C. Boothroyd T.P. Margolis Unusual abundance of atypical strains associated with human ocular toxoplasmosis J Infect Dis 184 2001 633 639
12. J.P. Saeij J.P. Boyle J.C. Boothroyd Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host Trends Parasitol 21 2005 476 481
13. D.G. Mack J.J. Johnson F. Roberts HLA-class II genes modify outcome of Toxoplasma gondii infection Int J Parasitol 29 1999 1351 1358
14. C. Briatte Study of 55 Cases of Congenital Toxoplasmosis Detected at the Time of Systematic Medical Check-ups after 10 Months of Age [dissertation] 1980 Faculté de Médecine Saint-Antoine Paris
15. J. Couvreur G. Desmonts D. Aron-Rosa Ocular prognosis in congenital toxoplasmosis: the role of treatment Preliminary communication [in French] Ann Pediatr (Paris) 31 1984 855 858
16. J. Couvreur G. Desmonts G. Tournier M. Szusterkac A homogeneous series of 210 cases of congenital toxoplasmosis in 0 to 11-month-old infants detected prospectively [in French] Ann Pediatr (Paris) 31 1984 815 819
17. G. Desmonts J. Couvreur Congenital toxoplasmosis: prospective study of the outcome of pregnancy in 542 women with toxoplasmosis acquired during pregnancy [in French] Ann Pediatr (Paris) 31 1984 805 809
18. A. Rothova Ocular involvement in toxoplasmosis Br J Ophthalmol 77 1993 371 377
19. A. Rothova Ocular manifestations of toxoplasmosis Curr Opin Ophthalmol 14 2003 384 388
20. R.W. Portela J. Bethony M. Costa A multihousehold study reveals a positive correlation between age, severity of ocular toxoplasmosis, and levels of glycoinositolphospholipid-specific immunoglobulin A J Infect Dis 190 2004 175 183
21. F. Roberts M.B. Mets D.J. Ferguson Histopathological features of ocular toxoplasmosis in the fetus and infant Arch Ophthalmol 119 2001 51 58
22. N.G. Guerina H.W. Hsu H.C. Meissner Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection N Engl J Med 330 1994 1858 1863
23. M. Wallon L. Kodjikian C. Binquet Long-term ocular prognosis in 327 children with congenital toxoplasmosis Pediatrics 113 2004 1567 1572
24. L. Kodjikian M. Wallon J. Fleury Ocular manifestations in congenital toxoplasmosis Graefes Arch Clin Exp Ophthalmol 244 2006 14 21